Univ. of Texas, MD Anderson Cancer Center

Houston, Texas 77030

1 studies enrolling now · 6 studies all time

What they study most

BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Blast Phase, Cancer, Leukemia, Myeloid, Acute, Lymphoma, Lymphomas, Myeloid Leukemia, Chronic, Myeloid Leukemia, Chronic, Accelerated-Phase, Myeloid Leukemia, Chronic, Chronic-Phase, Nipple Sparing Mastectomy, Thyroid Carcinoma

Studies at this site

• Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer — Recruiting now
• Open Nipple Sparing Mastectomy (NSM) — Running, not enrolling
• Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma — Completed
• Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML) — Stopped early
• Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies — Completed
• Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) — Stopped early